Clinical Trials Directory

Trials / Unknown

UnknownNCT04321083

Measurement of Cerebral rSO2 Levels During Sleep in Children With Suspected Obstructive Sleep Apnea

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Tel-Aviv Sourasky Medical Center · Other Government
Sex
All
Age
4 Years – 16 Years
Healthy volunteers
Not accepted

Summary

The gold standard of obstructive sleep apnea (OSA) is (PSG)POLYSOMNOGRAPHY. During the examination, the patient is monitored by saturation, EEG and other measurements. Near infrared spectroscopy is an uprising technology allowing non invasive measurement of the frontal lobe oxygenation. It is painless and does not have side effects. We believe that brain saturation will be more accurate then peripheral pulse oximeter and will be better correlated with the clinical presentation of OSA.

Detailed description

a prospective cohort study study group - pediatric population referred to PSG in Dana Duek Hospital. After informed consent received from the parents, the parents will fulfill "Connors" (age 6 +) \& "Brief" (age 4-6) questionnaires. During the PSG, the brain saturation will be monitored by INVOS(TM) Medtronic device. They will be monitored \& synchronized with the peripheral saturation documented performed as part of the PSG examination. The brain saturation \& peripheral saturation levels will be compared and both will be correlated to the questionnaires \& AHI.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTINVOSINVOS monitoring brain o2 saturation

Timeline

Start date
2019-09-11
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2020-03-25
Last updated
2020-03-25

Locations

1 site across 1 country: Israel

Regulatory

Source: ClinicalTrials.gov record NCT04321083. Inclusion in this directory is not an endorsement.